scholarly article | Q13442814 |
P50 | author | Aurora J Cruz-Cabeza | Q56161318 |
P2093 | author name string | Joel Bernstein | |
Susan M Reutzel-Edens | |||
P2860 | cites work | Open Babel: An open chemical toolbox | Q21198766 |
From ultrasoft pseudopotentials to the projector augmented-wave method | Q21708488 | ||
Generalized Gradient Approximation Made Simple | Q25938998 | ||
Efficient iterative schemes for ab initio total-energy calculations using a plane-wave basis set | Q26778418 | ||
Projector augmented-wave method | Q26778419 | ||
Special points for Brillouin-zone integrations | Q26778424 | ||
Efficiency of ab-initio total energy calculations for metals and semiconductors using a plane-wave basis set | Q26778473 | ||
The predictably elusive form II of aspirin | Q28193640 | ||
Ritonavir: an extraordinary example of conformational polymorphism | Q28209247 | ||
On the polymorphism of aspirin: crystalline aspirin as intergrowths of two "polymorphic" domains | Q28211631 | ||
Disappearing Polymorphs | Q30054444 | ||
Estimating the relative stability of polymorphs and hydrates from heats of solution and solubility data | Q30666977 | ||
Crystalline polymorph selection and discovery with polymer heteronuclei. | Q31159462 | ||
Concomitant Polymorphs | Q33796983 | ||
Crystalline solids | Q34233888 | ||
Pharmaceutical co-crystals | Q34489354 | ||
High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids | Q35666929 | ||
Polymorph control: past, present and future | Q37110762 | ||
Crystal polymorphism in chemical process development. | Q37995275 | ||
Lead- and drug-like compounds: the rule-of-five revolution | Q38225014 | ||
Pharmaceutical Applications of Polymorphism | Q39984474 | ||
Crystal Polymorphism in Oxalyl Dihydrazide: Is Empirical DFT-D Accurate Enough? | Q40292270 | ||
Abundant polymorphism in a system with multiple hydrogen-bonding opportunities: oxalyl dihydrazide | Q40312235 | ||
Validation of experimental molecular crystal structures with dispersion-corrected density functional theory calculations. | Q41909203 | ||
Universal prediction of intramolecular hydrogen bonds in organic crystals | Q44272698 | ||
Persistent hydrogen bonding in polymorphic crystal structures | Q44780563 | ||
Solvent-drop grinding: green polymorph control of cocrystallisation | Q44815137 | ||
Many-body dispersion interactions in molecular crystal polymorphism | Q46352629 | ||
Modeling the interplay of inter- and intramolecular hydrogen bonding in conformational polymorphs | Q46501986 | ||
Conformational polymorphism in organic crystals | Q46695334 | ||
Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients | Q46699552 | ||
Polymorphism in benzamide | Q46750666 | ||
Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine | Q46923641 | ||
Accurate and efficient method for many-body van der Waals interactions | Q50058276 | ||
The polymorphs of ROY: application of a systematic crystal structure prediction technique. | Q50500185 | ||
Carboxamide-pyridine N-oxide heterosynthon for crystal engineering and pharmaceutical cocrystals. | Q51243818 | ||
Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? | Q51624915 | ||
Semiempirical GGA-type density functional constructed with a long-range dispersion correction. | Q51629241 | ||
Conformational polymorphism. | Q54422319 | ||
New software for searching the Cambridge Structural Database and visualizing crystal structures | Q56161328 | ||
Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development | Q56443341 | ||
Diversity in Single- and Multiple-Component Crystals. The Search for and Prevalence of Polymorphs and Cocrystals | Q56769799 | ||
Polymorphism in Benzamide: Solving a 175-Year-Old Riddle | Q56851956 | ||
Static and lattice vibrational energy differences between polymorphs | Q56851957 | ||
Crystal Structure Prediction of a Flexible Molecule of Pharmaceutical Interest with Unusual Polymorphic Behavior | Q57393671 | ||
Symmetry Breaking: Polymorphic Form Selection by Enantiomers of the Melatonin Agonist and Its Missing Polymorph | Q57393680 | ||
Molecule VI, a Benchmark Crystal-Structure-Prediction Sulfonimide: Are Its Polymorphs Predictable? | Q57393683 | ||
Wöhler and Liebig Revisited: 176 Years of Polymorphism in Benzamide - and the Story Still Continues!† | Q57707381 | ||
Oxalyl dihydrazide polymorphism: a periodic dispersion-corrected DFT and MP2 investigation | Q57887057 | ||
P433 | issue | 23 | |
P304 | page(s) | 8619-8635 | |
P577 | publication date | 2015-09-24 | |
P1433 | published in | Chemical Society Reviews | Q2962268 |
P1476 | title | Facts and fictions about polymorphism | |
P478 | volume | 44 |
Q61799308 | 3D energy frameworks of dimethylbenzophenone tetramorphs |
Q48131499 | A Sequential Method to Prepare Polymorphs and Solvatomorphs of [Fe(1,3-bpp)2 ](ClO4 )2 ⋅nH2 O (n=0, 1, 2) with Varying Spin-Crossover Behaviour. |
Q50026858 | A novel dihydrocoumarin under experimental and theoretical characterization. |
Q92820971 | A review on possible mechanisms of sonocrystallisation in solution |
Q47929137 | Ab initio random structure searching of organic molecular solids: assessment and validation against experimental data. |
Q42359623 | Accurate and efficient representation of intramolecular energy in ab initio generation of crystal structures. I. Adaptive local approximate models. |
Q48313049 | Alloying barbituric and thiobarbituric acids: from solid solutions to a highly stable keto co-crystal form. |
Q57094761 | An NMR Crystallography Investigation of Furosemide |
Q92939063 | Bulk and Surface-Stabilized Structures of Paracetamol Revisited by Raman Confocal Microscopy |
Q47645961 | CO2 packing polymorphism under pressure: Mechanism and thermodynamics of the I-III polymorphic transition |
Q38805031 | Can computed crystal energy landscapes help understand pharmaceutical solids? |
Q51088651 | Challenges in Translational Development of Pharmaceutical Cocrystals. |
Q92945401 | Charge Distributions of Nitro Groups Within Organic Explosive Crystals: Effects on Sensitivity and Modeling |
Q89747700 | Charge mobility calculation of organic semiconductors without use of experimental single-crystal data |
Q49496136 | Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability |
Q59133311 | Conformational aspects of polymorphs and phases of 2-propyl-1-benzimidazole |
Q98893753 | Consequences of hidden kinetic pathways on supramolecular polymerization |
Q58561586 | Control and prediction of the organic solid state: a challenge to theory and experiment |
Q38364885 | Convergence Properties of Crystal Structure Prediction by Quasi-Random Sampling |
Q47108288 | Crystal structures of {μ2-N,N'-bis-[(pyridin-3-yl)meth-yl]ethanedi-amide}tetra-kis-(di-methyl-carbamodi-thio-ato)dizinc(II) di-methyl-formamide disolvate and {μ2-N,N'-bis-[(pyridin-3-yl)meth-yl]ethanedi-amide}tetra-kis-(di-n-propyl-carbamodi-thio-at |
Q90186089 | Evaluating Computational Shortcuts in Supercell-Based Phonon Calculations of Molecular Crystals: The Instructive Case of Naphthalene |
Q57827086 | Experimental and Computational Hydrate Screening: Cytosine, 5-Flucytosine and Their Solid Solution |
Q50063756 | Fast and accurate quantum Monte Carlo for molecular crystals. |
Q57663723 | First-principles modeling of molecular crystals: structures and stabilities, temperature and pressure |
Q48049975 | From dimers to the solid-state: Distributed intermolecular force-fields for pyridine |
Q41701506 | Functional materials discovery using energy-structure-function maps |
Q39532863 | Generation of crystal structures using known crystal structures as analogues |
Q46281625 | How important is thermal expansion for predicting molecular crystal structures and thermochemistry at finite temperatures? |
Q57599069 | Hydrate Networks under Mechanical Stress - A Case Study for Co3(PO4)2·8H2O |
Q89895285 | Interplay between Polymorphism and Isostructurality in the 2-Fur- and 2-Thenaldehyde Semi- and Thiosemicarbazones |
Q41522278 | Making crystals with a purpose; a journey in crystal engineering at the University of Bologna. |
Q30357005 | Modelling temperature-dependent properties of polymorphic organic molecular crystals. |
Q41597281 | Non-intuitive clustering of 9,10-phenanthrenequinone on Au(111) |
Q98726813 | One mol-ecule, three crystal structures: conformational trimorphism of N-[(1S)-1-phenyl-eth-yl]benzamide |
Q90448380 | Overcoming the difficulties of predicting conformational polymorph energetics in molecular crystals via correlated wavefunction methods |
Q38632654 | Pharmaceutical cocrystals: along the path to improved medicines |
Q92716410 | Polymorph evolution during crystal growth studied by 3D electron diffraction |
Q37135576 | Polymorphism in phenobarbital: discovery of a new polymorph and crystal structure of elusive form V. |
Q64068420 | Polymorphism of the dinuclear Co-Schiff base complex [Co(o-van-en)]·4CHCN (o-van-en is a salen-type ligand) |
Q46430523 | Porous materials: Designed and then realized |
Q50065836 | Predicting anisotropic thermal displacements for hydrogens from solid-state NMR: a study on hydrogen bonding in polymorphs of palmitic acid |
Q99578768 | Pressure-Promoted Solvation of Resorcinol |
Q61797094 | Reliable and practical computational description of molecular crystal polymorphs |
Q38752327 | Solvation and surface effects on polymorph stabilities at the nanoscale |
Q41671576 | Stoichiometric and Non-Stoichiometric Hydrates of Brucine |
Q53438493 | Supramolecular Organization of Nonstoichiometric Drug Hydrates: Dapsone. |
Q92946241 | Supramolecular Similarity in Polymorphs: Use of Similarity Indices (IX) |
Q39263322 | Supramolecular materials |
Q54943838 | Survey and analysis of crystal polymorphism in organic structures. |
Q92446701 | The Polymorphism of Drugs: New Approaches to the Synthesis of Nanostructured Polymorphs |
Q93046228 | Tuning Solid-State Luminescence in Conjugated Organic Materials: Control of Excitonic and Excimeric Contributions through π Stacking and Halogen Bond Driven Self-Assembly |
Q57826942 | Understanding the Role of Water in 1,10-Phenanthroline Monohydrate |
Q42276818 | Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few? |
Q38697551 | Why do Hydrates (Solvates) Form in Small Neutral Organic Molecules? Exploring the Crystal Form Landscapes of the Alkaloids Brucine and Strychnine. |
Q91974069 | X-ray diffraction data as a source of the vibrational free-energy contribution in polymorphic systems |
Q55998525 | [Pt(SCN)4 ]2- -Based Coordination Polymers and Supramolecular Squares: Intermolecular Pt···H-C Interactions Probed by Luminescence Spectroscopy at Variable Pressure |